ANDA 210680, held by Rubicon Research. Clonidine Hydrochloride.
As of Nov 16, 2026, ANDA 210680 (Clonidine Hydrochloride), held by Rubicon Research, was first approved by FDA on Apr 30, 2018, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 2018 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clonidine Hydrochloride0.1MG · tablet, extended release;oral | Clonidine Hydrochloride | Discontinued |
| May 29, 2020 | Supplement 1Labeling · Standard review | Approved | None posted |
| Apr 30, 2018 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters